VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price was down 6.1% on Friday . The stock traded as low as C$0.16 and last traded at C$0.16. Approximately 15,600 shares changed hands during trading, a decline of 83% from the average daily volume of 90,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Price Performance
The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of 217.41. The stock has a fifty day simple moving average of C$0.18 and a 200-day simple moving average of C$0.20. The stock has a market cap of C$24.36 million, a price-to-earnings ratio of -5.17 and a beta of 0.39.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- How to Invest in Insurance Companies: A Guide
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- What Are Dividend Champions? How to Invest in the Champions
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Find and Profitably Trade Stocks at 52-Week Lows
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
